ENvue Medical Inc (FEED)

FEED..............................https://stockcharts.com/sc3/ui/?s=FEED&p=w&b=5&g=0&id=p86431144783

ENvue Medical expands U.S. hospital footprint to 39 sites with Detroit system purchaseMarch 24, 2026 10:58 AM
IH Market News
ENvue Medical, Inc. (NASDAQ:FEED) announced Monday that a 714-bed teaching hospital and Level I Trauma Center in the Detroit metropolitan area has purchased its ENvue Navigation Platform system along with compatible feeding tubes.The acquisition expands the company’s presence within a Southeast Michigan health system where its technology has previously been deployed, increasing ENvue’s total U.S. hospital footprint to 39 facilities, according to a company press release. The update comes as ENvue’s shares trade around $1.43, down roughly 96% over the past year, leaving the company with a market capitalization of about $1.56 million.The Detroit-area facility is a major teaching hospital within a regional health network and includes specialized institutes focused on oncology, cardiovascular care and pediatrics. The hospital operates medical, pediatric, surgical and cardiovascular intensive care units, along with a Level III Neuro-ICU.“Preeminent teaching and non-teaching hospitals alike are seeking innovative technologies that can improve workflow efficiency while supporting cost containment and patient safety initiatives,” said Marc Waldman, Vice President of Commercial at ENvue Medical.The ENvue Navigation Platform is a minimally invasive electromagnetic navigation system designed to help clinicians place feeding tubes within the gastrointestinal tract. The device received FDA 510(k) clearance for adult use and provides real-time bedside visualization of tube movement during placement procedures.“This expansion within a leading Michigan health system reflects continued momentum in our commercial execution for the ENvue Navigation Platform,” said Doron Besser, Chief Executive Officer of ENvue Medical.The company’s commercial progress comes despite financial challenges.Headquartered in Tyler, Texas, ENvue Medical develops non-invasive technologies for enteral care used in both clinical and home healthcare settings. The company also operates research and development centers in Tel Aviv and Nesher, Israel.According to ENvue, future platform developments may include applications for pediatric care and vascular access.In other recent developments, the United States Patent and Trademark Office issued a Notice of Allowance for ENvue’s patent application covering a feeding tube design that integrates electromagnetic navigation with a distal-tip camera. The patent includes 18 claims and is intended to improve feeding tube placement by combining positional guidance with direct visualization.The company also entered into a distribution agreement with U-Deliver to broaden access to its ENFit syringes through non-acute care channels across the United States. The partnership will leverage U-Deliver’s digital and wholesale networks to expand distribution in home healthcare and long-term care settings.Separately, ENvue appointed Marc Waldman as Vice President, Commercial, where he will oversee U.S. commercialization strategy and efforts to grow the company’s hospital customer base beyond the current network of facilities.ENvue has also amended its Long Term Incentive Plan to comply with Israeli tax regulations, introducing restricted stock units and other awards under Section 102. The update also reflects the company’s recent corporate name change from NanoVibronix, Inc. to ENvue Medical, Inc. These developments highlight ENvue’s ongoing efforts to strengthen product innovation, expand distribution and align with regulatory requirements.ENvue Medical stock price

Original: ENvue Medical expands U.S. hospital footprint to 39 sites with Detroit system purchase

Buys near double the sells
https://investorshub.advfn.com/stock-market/NASDAQ/envue-medical-FEED/trades

Nice breakout today,still zero borrow holding strong for weeks now

If the floor price for the series H preferred shares was removed, then how is that bullish? That means that the preferred shares can now convert at any price? Whats stopping them from doing it?

Up halt out the gate,zero borrow/600% fee,1m float

securing capital/flexibility

For those following $FEED (Envue Medical), here's the recent 8-K on the Series H amendment (removal of floor price in exchange for $2.5M investment exercise). Effective Jan 30, 2026.

https://www.sec.gov/Archives/edgar/data/1326706/000149315226004523/form8-k.htm

$FEED: Tapped $4.80 !!!!!!!!!!!!!!!!

Who's having this much fun ?????????????????

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177172949

Whatttttssssssssss my nameeeeeeeeeeeeeeeeee ??????????




GO $FEED

$4 coming up AH

$FEED: Bid filled at $1.05..................... NICE RAMPPPPPppppppppppppppp

Good thing I loaded up big.

Now at $2.50 !!!!!!!!!!!

Cmon loyal followers..................... comp me an iHub subscription for the YEAR, been giving you all these BANNGERS !!!!!!!


GO $FEED

Thankyou for the reply i appreciate it!

$FEED: Not yet............. but soon


Looks like there is more to let go of here.................... got a bid in but it might be too low so I'll raise it tomorrow


Now at $1.25

GO $FEED

Hi may i ask are you back in? Thankyou not financial advice

$FEED: Back in for 15k here at $2

Give this another try

$1.90 stop


GO $FEED

$FEED: Stopped out

Dammmmmmmmmmmmmmmm it

GO $FEED

$FEED: ADded 8k here at $2.80 dip............

LFG babyyyyyyyyyyyyyyyy.............. they ringing the opening bell.


Got a $2.60 stop


GO $FEED

$FEED: BOOOoommmmmmmmmm................ now over $3

Nice lil boost here in PM........... from $2.20 yesterday.
Only 1Milly floater

Offffff she goes..............

Nvue Medical Launches Over-the-Counter Reusable ENFit Syringes For Feeding And Medication Delivery


GO $FEED